Flubromazolam is not really recognized to own any therapeutic use, is not really to the WHO Product Listing of Critical Medicines and has never been promoted to be a medicinal product or service.The metabolism of flubromazolam is hepatic and is also no less than partly mediated with the CYP3A4/5 and UGT1A4 enzymes [two], which suggests that enzyme